Your browser doesn't support javascript.
loading
Diabetic Retinopathy Clinical Practice Guidelines: Customized for Iranian Population.
Rajavi, Zhale; Safi, Sare; Javadi, Mohammad Ali; Azarmina, Mohsen; Moradian, Siamak; Entezari, Morteza; Nourinia, Ramin; Ahmadieh, Hamid; Shirvani, Armin; Shahraz, Saeid; Ramezani, Alireza; Dehghan, Mohammad Hossein; Shahsavari, Mohsen; Soheilian, Masoud; Nikkhah, Homayoun; Ziaei, Hossein; Behboudi, Hasan; Farrahi, Fereydoun; Falavarjani, Khalil Ghasemi; Parvaresh, Mohammad Mehdi; Fesharaki, Hamid; Abrishami, Majid; Shoeibi, Nasser; Rahimi, Mansour; Javadzadeh, Alireza; Karkhaneh, Reza; Riazi-Esfahani, Mohammad; Manaviat, Masoud Reza; Maleki, Alireza; Kheiri, Bahareh; Golbafian, Faegheh.
Afiliación
  • Rajavi Z; Ophthalmic Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran; Ophthalmic Epidemiology Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
  • Safi S; Ophthalmic Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran; Ophthalmic Epidemiology Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
  • Javadi MA; Ophthalmic Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
  • Azarmina M; Ophthalmic Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
  • Moradian S; Ophthalmic Epidemiology Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
  • Entezari M; Ophthalmic Epidemiology Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
  • Nourinia R; Ophthalmic Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
  • Ahmadieh H; Ophthalmic Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
  • Shirvani A; Standardization and CPG Development Office, Deputy of Curative Affairs, Ministry of Health and Medical Education, Tehran, Iran.
  • Shahraz S; Tufts Medical Center, Boston, Massachusetts, USA.
  • Ramezani A; Ophthalmic Epidemiology Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran; Department of Ophthalmology, Imam Hossein Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
  • Dehghan MH; Ophthalmic Epidemiology Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran; Department of Ophthalmology, Labbafinejad Medical Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
  • Shahsavari M; Department of Ophthalmology, Labbafinejad Medical Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
  • Soheilian M; Ophthalmic Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran; Department of Ophthalmology, Labbafinejad Medical Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
  • Nikkhah H; Ophthalmic Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran; Department of Ophthalmology, Torfeh Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
  • Ziaei H; Ophthalmic Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran; Ophthalmic Epidemiology Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
  • Behboudi H; Department of Ophthalmology, Gilan University of Medical Sciences, Rasht, Iran.
  • Farrahi F; Department of Ophthalmology, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.
  • Falavarjani KG; Department of Ophthalmology, Rassoul Akram Hospital, Iran University of Medical Sciences, Tehran, Iran.
  • Parvaresh MM; Department of Ophthalmology, Rassoul Akram Hospital, Iran University of Medical Sciences, Tehran, Iran.
  • Fesharaki H; Department of Ophthalmology, Isfahan University of Medical Sciences, Isfahan, Iran.
  • Abrishami M; Department of Ophthalmology, Mashhad University of Medical Sciences, Mashhad, Iran.
  • Shoeibi N; Department of Ophthalmology, Mashhad University of Medical Sciences, Mashhad, Iran.
  • Rahimi M; Department of Ophthalmology, Shiraz University of Medical Sciences, Shiraz, Iran.
  • Javadzadeh A; Department of Ophthalmology, Tabriz University of Medical Sciences, Tabriz, Iran.
  • Karkhaneh R; Department of Ophthalmology, Farabi Eye Hospital, Tehran University of Medical Sciences, Tehran, Iran.
  • Riazi-Esfahani M; Department of Ophthalmology, Farabi Eye Hospital, Tehran University of Medical Sciences, Tehran, Iran.
  • Manaviat MR; Department of Ophthalmology, Yazd University of Medical Sciences, Yazd, Iran.
  • Maleki A; Department of Ophthalmology, Al Zahra Eye Center, Zahedan University of Medical Sciences, Zahedan, Iran.
  • Kheiri B; Ophthalmic Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
  • Golbafian F; Victoria Family Medical Centre, UWO, London, ON, Canada.
J Ophthalmic Vis Res ; 11(4): 394-414, 2016.
Article en En | MEDLINE | ID: mdl-27994809
PURPOSE: To customize clinical practice guidelines (CPGs) for management of diabetic retinopathy (DR) in the Iranian population. METHODS: Three DR CPGs (The Royal College of Ophthalmologists 2013, American Academy of Ophthalmology [Preferred Practice Pattern 2012], and Australian Diabetes Society 2008) were selected from the literature using the AGREE tool. Clinical questions were designed and summarized into four tables by the customization team. The components of the clinical questions along with pertinent recommendations extracted from the above-mentioned CPGs; details of the supporting articles and their levels of evidence; clinical recommendations considering clinical benefits, cost and side effects; and revised recommendations based on customization capability (applicability, acceptability, external validity) were recorded in 4 tables, respectively. Customized recommendations were sent to the faculty members of all universities across the country to score the recommendations from 1 to 9. RESULTS: Agreed recommendations were accepted as the final recommendations while the non-agreed ones were approved after revision. Eventually, 29 customized recommendations under three major categories consisting of screening, diagnosis and treatment of DR were developed along with their sources and levels of evidence. CONCLUSION: This customized CPGs for management of DR can be used to standardize the referral pathway, diagnosis and treatment of patients with diabetic retinopathy.
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Guideline Idioma: En Revista: J Ophthalmic Vis Res Año: 2016 Tipo del documento: Article País de afiliación: Irán Pais de publicación: Emiratos Árabes Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Guideline Idioma: En Revista: J Ophthalmic Vis Res Año: 2016 Tipo del documento: Article País de afiliación: Irán Pais de publicación: Emiratos Árabes Unidos